X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 12/07/2024 17:05

Study reveals potential cognitive benefits of antidiabetic drugs

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.

Articles similaires

Sorry! Image not available at this time

Double Duty Drug: Could Your Diabetes Drug Fight Autoimmunity?

medindia.net - 21/Oct 11:55

bA medlinktype 2 diabetes drug/medlink, sodium-glucose cotransporter-2 (SGLT-2) inhibitors, is associated with an 11% lower risk of developing...

Sorry! Image not available at this time

SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D

drugs.com - 23/Oct 16:10

THURSDAY, Oct. 23, 2025 -- Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are associated with a reduced risk for autoimmune rheumatic diseases...

Sorry! Image not available at this time

New diabetes drugs may better prevent dementia than metformin

knowridge.com - 18/Oct 10:20

A new large study suggests that a group of diabetes medications called GLP-1 receptor agonists may be better than metformin at protecting the brain...

Sorry! Image not available at this time

CHEST: SGLT2 Inhibitors May Slow Nodule Growth in Pulmonary Malignancies

drugs.com - 20/Oct 16:10

MONDAY, Oct. 20, 2025 -- For patients with diabetes and early-stage pulmonary malignancies, administration of a sodium-glucose cotransporter 2...

Sorry! Image not available at this time

Diabetes Drugs, Jardiance and Insulin Nasal Spray, Might Counter Brain Decline In Early Alzheimer's Patients

drugs.com - 21/Oct 10:10

TUESDAY, Oct. 21, 2025 — Two widely available diabetes medications appear to safely improve brain health among people with early brain...

Sorry! Image not available at this time

CHEST: Mortality Down With GLP-1 Receptor Agonist Use in T2D, Especially in Those With OSA

drugs.com - 20/Oct 15:51

MONDAY, Oct. 20, 2025 -- Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have...

Sorry! Image not available at this time

Diabetes Drugs Might Counter Brain Decline In Early Alzheimer's Patients

wn.com - 21/Oct 13:45

Key Takeaways ......

Sorry! Image not available at this time

Diabetes Drugs Might Counter Brain Decline In Early Alzheimer's Patients

wn.com - 21/Oct 14:14

Key Takeaways ......

Sorry! Image not available at this time

Diabetes Drugs Might Counter Brain Decline In Early Alzheimer's Patients

wn.com - 21/Oct 21:20

Key Takeaways ......

Sorry! Image not available at this time

Empagliflozin and Intranasal Insulin May Slow Alzheimer's Decline

medindia.net - 23/Oct 12:04

Highlights: Diabetes and heart medications show powerful effects on brain health in Alzheimer's disease Intra

Les derniers communiqués